It thus became the first prominent Chinese company to halt its US IPO plans after Beijing cracked down on domestic companies listing overseas. By PYMNTS Chinese medical data startup LinkDoc Technology is planning to raise 500 million in an initial public offering (IPO), Bloomberg reported, citing sources. Na Hou & Jie Zhang & Qianying Zhu & Sijia Zhong & Wenwen Liu & Jihua Zhang, 2021. Healthcare künstliche Intelligenz China Mit LinkDoc bereitet das nächste chinesische Unternehmen sein IPO an der Nasdaq vor.
Their first quarter revenue for this year was RMB 223 million yuan, up by RMB 159 million yuan from the same period of 2020.īut in July, LinkDoc scrapped plans to list due to market volatility. SEE ALSO: LinkDoc to List on NASDAQ, Sets Sights on $1.5 Billion Market ValueĪccording to the prospectus disclosed by the company itself, the company’s revenue in 20 were RMB 374 million yuan and RMB 942 million yuan respectively, with a year-on-year increase of 89%.
At that time, it was set to raise as much as $211 million from issuing $10.8 million shares at a price of $17.50 to $19.50. ITJUZI English news channel is a platform for real-time investment deals included by ITJUZI, covering the newest and the most comprehensive financing information for industries of mobile. In June this year, LinkDoc officially submitted its prospectus to the US Securities and Exchange Commission (SEC) and planned to list on the Nasdaq. The service will work by connecting APPs such as the Ali Health platform with the LinkDoc Internet Hospital and Cancer Patient Service Center. The two sides announced that they will build a patient-centered and innovation-driven service platform, which provides whole-cycle support for cancer patients. In March this year, Alibaba Health made a strategic investment in the company. Since 2015, the company has completed five rounds of financing with investors such as Alibaba Health, Youshan Capital, CBC Capital, Ally Bridge Group and others. They added that the specific plan and details of the Pre-IPO and the Hong Kong IPO could still change.įounded in 2014, LinkDoc specializes in providing big data and artificial intelligence solutions for all parties in the pharmaceutical and medical industries. probably owes to two major factors: its urgent need of cash and also its realization that it might need to get a data security review before making such a listing. According to Bloomberg, LinkDoc Technology Limited, a medical data platform company backed by Alibaba Group, plans to lead a $200 to $300 million financing round before its upcoming IPO in Hong Kong.Ī person familiar with the matter said such a plan is still under discussion and no decision has been made yet.
0 kommentar(er)
